sucrose has been researched along with Pancreatic Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, LT; Dito, E; Ko, AH; Lin, YL; Ong, A; Shan, YS; Su, WC; Tempero, MA; Wang, YW; Yeh, CG | 1 |
| Saif, MW | 1 |
| Carnevale, J; Ko, AH | 1 |
| Chang, JY; Chen, LT; Chiang, NJ; Shan, YS | 1 |
| Henderson, BE; Kolonel, LN; Murphy, SP; Nöthlings, U; Wilkens, LR | 1 |
| Briand, P; Cartier, N; Kahn, A | 1 |
| Giroix, MH; Malaisse, WJ; Sener, A | 1 |
2 review(s) available for sucrose and Pancreatic Neoplasms
| Article | Year |
|---|---|
MM-398 (nanoliposomal irinotecan): emergence of a novel therapy for the treatment of advanced pancreatic cancer.
Topics: Animals; Antineoplastic Agents; Camptothecin; Clinical Trials as Topic; Drug Combinations; Drug Discovery; Drug Evaluation, Preclinical; Humans; Neoplasm Staging; Pancreatic Neoplasms; Sucrose; Treatment Outcome | 2016 |
Development of nanoliposomal irinotecan (nal-IRI, MM-398, PEP02) in the management of metastatic pancreatic cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Disease-Free Survival; Drug Combinations; Fluorouracil; Humans; Leucovorin; Pancreatic Neoplasms; Sucrose; Treatment Outcome | 2016 |
2 trial(s) available for sucrose and Pancreatic Neoplasms
| Article | Year |
|---|---|
A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Camptothecin; Disease-Free Survival; Drug Combinations; Female; Humans; Irinotecan; Liposomes; Male; Middle Aged; Pancreatic Neoplasms; Salvage Therapy; Sucrose; Treatment Outcome | 2013 |
MM-398 achieves primary endpoint of overall survival in phase III study in patients with gemcitabine refractory metastatic pancreatic cancer.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Deoxycytidine; Drug Combinations; Drug Resistance, Neoplasm; Gemcitabine; Humans; Pancreatic Neoplasms; Sucrose | 2014 |
3 other study(ies) available for sucrose and Pancreatic Neoplasms
| Article | Year |
|---|---|
Dietary glycemic load, added sugars, and carbohydrates as risk factors for pancreatic cancer: the Multiethnic Cohort Study.
Topics: Aged; Body Mass Index; Cohort Studies; Dietary Carbohydrates; Female; Fructose; Fruit; Humans; Insulin Resistance; Male; Middle Aged; Pancreatic Neoplasms; Risk Factors; Sucrose | 2007 |
[The creation of diet-dependent cancer models using transgenesis in animals].
Topics: Animals; Antigens, Polyomavirus Transforming; Diet; Dietary Carbohydrates; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Genes, myc; Hyperplasia; Liver; Liver Neoplasms, Experimental; Mice; Mice, Transgenic; Oncogenes; Pancreas; Pancreatic Neoplasms; Polyomavirus; Pyruvate Kinase; Sucrose | 1994 |
D-glucose transport and concentration in tumoral insulin-producing cells.
Topics: Adenoma, Islet Cell; Animals; Carbon Radioisotopes; Cell Line; Glucose; Insulinoma; Kinetics; Monosaccharide Transport Proteins; Pancreatic Neoplasms; Rats; Stereoisomerism; Sucrose | 1986 |